Article
All-trans retinoic acid (ATRA) reduces proliferative capacity and Brachyury levels in chordoma cells
2020-01-09
Abstract excerpt
Chordoma is a rare bone cancer for which there are no approved drugs. Surgery is the principle treatment but complete resection can be challenging due to the location of the tumours in the spine and therefore finding an effective drug treatment is a pressing unmet clinical need. A major recent study identified the transcription factor Brachyury as the primary vulnerability and drug target in chordoma. Previously,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 45f75eee-f078-5b7b-b08d-b604b61f6a1a
- DOI
- 10.1101/2020.01.09.897314
